TrialBMC infectious diseases2023

Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial.

Ramin Hamidi Farahani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.